Gemzar (gemcitabine) and Alimta (pemetrexed) in the treatment of patients with recurrent platinum-sensitive and platinum-resistant ovarian or peritoneal cancer
Phase of Trial: Phase II
Latest Information Update: 10 Sep 2005
At a glance
- Drugs Gemcitabine; Pemetrexed
- Indications Ovarian cancer; Peritoneal cancer
- Focus Therapeutic Use
- 10 Sep 2005 New trial record.